These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9049219)

  • 1. Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation.
    Segal H; Cottam S; Potter D; Hunt BJ
    Hepatology; 1997 Mar; 25(3):683-8. PubMed ID: 9049219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Downing A; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1994 Dec; 58(12):1356-60. PubMed ID: 7528949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1995 Feb; 59(3):366-70. PubMed ID: 7532878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y; Liu Y; Han R; Zhu Z; Zhang Y; Wang X; Wang L; Shen Z
    Thromb Res; 2008; 122(2):161-6. PubMed ID: 18048090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
    Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation.
    Levitsky J; Hart J; Cohen SM; Te HS
    Liver Transpl; 2003 Jul; 9(7):733-6. PubMed ID: 12827561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. S. Orsola Working Group on Liver Transplantation.
    Palareti G; Legnani C; Maccaferri M; Gozzetti G; Mazziotti A; Martinelli G; Zanello M; Sama C; Coccheri S
    Haemostasis; 1991; 21(2):68-76. PubMed ID: 1959800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of fibrinolysis in orthotopic liver transplantation.
    Cheema SP; Webster NR; Dunn F; Bellamy MC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
    Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
    Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.
    Mattalia A; Lüttig B; Rosina F; Leung PS; Van de Water J; Bauducci M; Ciancio A; Böker KH; Worman H; Cooper RL; Manns M; Ansari A; Rizzetto M; Gershwin ME
    J Autoimmun; 1997 Oct; 10(5):491-7. PubMed ID: 9376077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
    Leaker MT; Brooker LA; Mitchell LG; Weitz JI; Superina R; Andrew ME
    Transplantation; 1995 Jul; 60(2):144-7. PubMed ID: 7624956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome.
    Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG
    Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver transplantation for primary biliary cirrhosis].
    Mentha G; Huber O; Le Coultre C; Widmann JJ; Meyer P; Klopfenstein C; Morel P; Suter P; Rohner A
    Schweiz Med Wochenschr; 1992 Apr; 122(17):648-51. PubMed ID: 1589740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.
    Lisman T; Leebeek FW; Meijer K; Van Der Meer J; Nieuwenhuis HK; De Groot PG
    Hepatology; 2002 Mar; 35(3):616-21. PubMed ID: 11870375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.